Style | Citing Format |
---|---|
MLA | Omidian A, et al.. "Determination of Plasma and Erythrocyte Levels of Copper, Magnesium and Zinc by Atomic Absorption Spectrometry in Type-2 Diabetes Mellitus Patients With Metabolic Syndrome." Research in Pharmaceutical Sciences, vol. 17, no. 1, 2022, pp. 86-98. |
APA | Omidian A, Pourfarzam M, Ghanadian S, Zadhoush F (2022). Determination of Plasma and Erythrocyte Levels of Copper, Magnesium and Zinc by Atomic Absorption Spectrometry in Type-2 Diabetes Mellitus Patients With Metabolic Syndrome. Research in Pharmaceutical Sciences, 17(1), 86-98. |
Chicago | Omidian A, Pourfarzam M, Ghanadian S, Zadhoush F. "Determination of Plasma and Erythrocyte Levels of Copper, Magnesium and Zinc by Atomic Absorption Spectrometry in Type-2 Diabetes Mellitus Patients With Metabolic Syndrome." Research in Pharmaceutical Sciences 17, no. 1 (2022): 86-98. |
Harvard | Omidian A et al. (2022) 'Determination of Plasma and Erythrocyte Levels of Copper, Magnesium and Zinc by Atomic Absorption Spectrometry in Type-2 Diabetes Mellitus Patients With Metabolic Syndrome', Research in Pharmaceutical Sciences, 17(1), pp. 86-98. |
Vancouver | Omidian A, Pourfarzam M, Ghanadian S, Zadhoush F. Determination of Plasma and Erythrocyte Levels of Copper, Magnesium and Zinc by Atomic Absorption Spectrometry in Type-2 Diabetes Mellitus Patients With Metabolic Syndrome. Research in Pharmaceutical Sciences. 2022;17(1):86-98. |
BibTex | @article{ author = {Omidian A and Pourfarzam M and Ghanadian S and Zadhoush F}, title = {Determination of Plasma and Erythrocyte Levels of Copper, Magnesium and Zinc by Atomic Absorption Spectrometry in Type-2 Diabetes Mellitus Patients With Metabolic Syndrome}, journal = {Research in Pharmaceutical Sciences}, volume = {17}, number = {1}, pages = {86-98}, year = {2022} } |
RIS | TY - JOUR AU - Omidian A AU - Pourfarzam M AU - Ghanadian S AU - Zadhoush F TI - Determination of Plasma and Erythrocyte Levels of Copper, Magnesium and Zinc by Atomic Absorption Spectrometry in Type-2 Diabetes Mellitus Patients With Metabolic Syndrome JO - Research in Pharmaceutical Sciences VL - 17 IS - 1 SP - 86 EP - 98 PY - 2022 ER - |